
Bluefin Foods Inc. is creating a better solution to supply the world with meat food products.
Market:
Exponential population growth combined with the continued rise of demand for meat products requires us to achieve a more sustainable and scalable food production method. If everyone were to have the same meat diet as the average American, current resources would only be able to feed 2.5 billion people, a quarter of expected population by 2050. In the next few years, the cell-cultured meat industry is expected to represent 10% of the total global meat market, valued at $140B.Technology:
Bluefin Foods is embracing novel technologies and scientific development to achieve a new and efficient production of cell-cultured meat around their four R&D verticals: cell-line, growth media, custom bioreactors, and scaffolding. Bluefin's objective is to develop a cost-effect and high-quality process of producing cell-cultured seafood to be a viable alternative to the traditional supply chain.Advantages:
- Novel approach specific to cell-cultured meat
- No pollutants, microplastics, contaminants or disease carriers
- Does not require overfishing of depleted fish stock
- Flexible production and logistics scaled with demand
Development Stage:
- Prototype
Patents Issued:
- Coming Soon
Select Publications:
- Coming Soon
Contact:
Website: www.bluefinfoods.comEmail: info@bluefinfoods.com
LinkedIn | Instagram @bluefinfoods
Graduated in 2022

January 27, 2022 | Bluefin Foods creates a better solution to supply the world with cell-cultured seafood and meat
Bluefin Foods Inc., which is part of the Magnify incubator at the California NanoSystems Institute at UCLA (CNSI) is a cell-cultured seafood company focused on bringing bluefin tuna sushi products to all the sushi lovers in the world. ...
Graduated Companies
- Adaptix
- Aneeve
- Aneuvo
- Appia Bio
- Bluefin Foods
- CarbonBuilt
- Carbonics
- Charlot Biosciences
- CBD Research Institute
- Cellmic
- Concrete-AI
- Craytex
- CytoLumina
- DARTS Sciences
- Electronucleics
- EP Dynamics
- Ferrologix
- Horizon PV
- Inspira
- Inston
- InvVax
- Kelvi
- Keyssa
- Kythera Biopharmaceuticals
- Librede
- Lucendi
- Matrix Sensors, Inc.
- MAX BioPharma
- MediSens Wireless
- MicrobeDx
- Millibatt
- MyoGene Bio
- Myst Therapeutics
- Nammi Therapeutics
- NanoClear
- NanoElectronic Imaging
- NanoH₂O
- Nanopixel Technologies
- National Institute of Cannabinoid Research (NICR)
- Octant
- Omega Biosystems
- Orchard Therapeutics
- Polyradiant
- Qwixel Therapeutics
- Restore Technologies
- Sardona Therapeutics
- SELFA
- Sixal
- Spectradyne Particle Analysis
- Tempo Therapeutics
- TrueCath
- U-Defi
- Valerion Therapeutics
- Vivibaba
- Zenomics
- Back to Portfolio